Adult Health

New Contrave Trials Approved by FDA

The pharmaceutical company Orexigen Therapeutics reached an agreement with the U.S. Food and Drug Administration for a heart-safety trial of the obesity drug Contrave. Regulatory officials worry that the previously rejected experimental drug may increase cardiovascular risks, which the placebo-controlled … Continue reading